OmicsX - Innovation Insights

OmicsX manages various online resources and provides actionable networking & marketing intelligence to Biotech & Pharma companies. @CroLinker @IdentifyEvents

[OmicsX - Innovation Insights @omicsx]

From ADCs to DACs: Why Catalytic Payloads Are the Next Turn in Oncology Biologics https://t.co/lxxX4ojVZU

[OmicsX - Innovation Insights @omicsx]

Cancer Targeting Molecules in Active Development in Europe - 2024 https://t.co/ST1i01h1vU

[OmicsX - Innovation Insights @omicsx]

Oncology Drug Development in Europe - A Snapshot https://t.co/SPBvDz0lmf

[OmicsX - Innovation Insights @omicsx]

Strategic Business Development Services @omicsx https://t.co/uRS7Kjo2ym
Day to Day basis provide complete insights on new emerging leads matches your business offerings thus keep your BD team a step ahead in first to introduce your service offerings to your future new clients.

[Hope Biosciences @hopebiosciences]

Banking stem cells is acquiring and storing your stem cells in a safe place so when you need them, they are ready for your withdrawal.
#StemCells #HopeBiosciences #HTX #HopeBio #NotAllStemCellsAreCreatedEqual #RegenerativeMedicine #Innovation #Biotechnology #CellTherapy #Science

[OmicsX - Innovation Insights @omicsx]

ImmunoOncology 2020 is available at $199 USD only. Promotion + Charity @ Next 48 Hrs - our year end agenda -https://t.co/ZLM3HwZ812 via @LinkedIn

[OmicsX - Innovation Insights @omicsx]

Global Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, De... https://t.co/wactkBWf3O via @YouTube

[OmicsX - Innovation Insights @omicsx]

Global Top 370 Neurology Startups – Key Technologies, Pipeline, Deals and Funding.
Early stage pipeline for Alzheimer’s Disease, Parkinson Disease, Pain Treatment, Multiple Sclerosis, Epilepsy, Ischemic Stroke & Traumatic Brain Injury and Schizophrenia. https://t.co/p3uLQHsfMq

[OmicsX - Innovation Insights @omicsx]

Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, Deals and Funding Analysis.
https://t.co/79PrG1UXOw

[OmicsX - Innovation Insights @omicsx]

Top 400 Immuno-Oncology Startups - Key Technologies, Pipeline, Deals and Funding Analysis https://t.co/RmgWG1Y0Di via @LinkedIn

[OmicsX - Innovation Insights @omicsx]

Top 400 Immuno-Oncology Startups - Key Technologies, Pipeline, Deals and Funding Analysis https://t.co/RmgWG1Y0Di via @LinkedIn

[OmicsX - Innovation Insights @omicsx]

Check out my latest article: Top 400 Immuno-Oncology Startups - Key Technologies, Pipeline, Deals and Funding Analysis https://t.co/RmgWG1Y0Di via @LinkedIn

[PrecisionLife @precisionlifeAI]

"We're targeting #medicine at the molecular makeup, not at the diagnostic label of the tumour." Check out this interview with our CEO, Steve Gardner (@showcasebio), courtesy of @singular_talent. https://t.co/qCmcJ5seB1 #pharma #biotech #drugdiscovery

[Pharmafocus @Pharmafocus]

Over half of all anti-vaccine ads on #Facebook stem from just two advertisers https://t.co/EfBgbNXxAm #pharma #vaccines

[Discovery Park @discoverypark_]

At Discovery Park, we don’t just work to make today a success, we’re always looking to tomorrow. #STEM education is a vital part of what we do, sparking a love of #science to last a lifetime. Learn more about #education https://t.co/rUdu3uD634

[Lumira Ventures @LumiraVentures]

Fantastic discussion yesterday at #BioMedInnovate on what Canada's #biomedical sector needs to facilitate large-scale #commercialization & a thriving #ecosystem with @bloomburton, @LumiraVentures @NovoNordiskCA & @ZymeworksInc brilliantly moderated by @SeanSilcoff @TheGlobeEvents

[Lineage Cell Therapeutics @LineageCell]

Today $LCTX announced positive additional results from an ongoing Phase I/IIa study of OpRegen, a therapy currently in development for the treatment of #dryAMD at #AAO2019. Listen below as CEO Brian Culley discusses the impact of these results.

Read more: https://t.co/0uNPpdfbrm

[NanOlogy LLC @NanOlogyLLC]

@NanOlogyLLC will be at #ACG2019 with presentations of data on intramural delivery of NanoPac® for #pancreaticcancer. Oct 28/29 in #SanAntonio. Details: https://t.co/hUA4uruHwn

[OmicsX - Innovation Insights @omicsx]

There are 2,004 cancer immunotherapies crowding into the pipeline. Now what? - https://t.co/PFubwxlTpr

[OmicsX - Innovation Insights @omicsx]

PhRMA's new report counts each cancer drug in the US pipeline, which has now swelled to over 1,000 in the clinic - https://t.co/fsOKddm4yw